nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—ovarian follicle—obesity	0.132	0.714	CbGeAlD
Goserelin—GNRHR—hindbrain—obesity	0.0184	0.0995	CbGeAlD
Goserelin—LHCGR—adipose tissue—obesity	0.0118	0.0637	CbGeAlD
Goserelin—Ceruletide—CCKAR—obesity	0.0115	0.875	CrCbGaD
Goserelin—LHCGR—endocrine gland—obesity	0.00916	0.0495	CbGeAlD
Goserelin—GNRHR—pituitary gland—obesity	0.00762	0.0412	CbGeAlD
Goserelin—GNRHR—endocrine gland—obesity	0.0059	0.0319	CbGeAlD
Goserelin—Pentagastrin—BCHE—obesity	0.00163	0.125	CrCbGaD
Goserelin—Ill-defined disorder—Sibutramine—obesity	0.000414	0.000905	CcSEcCtD
Goserelin—Anaemia—Sibutramine—obesity	0.000412	0.000901	CcSEcCtD
Goserelin—Osteoarthritis—Topiramate—obesity	0.000412	0.000899	CcSEcCtD
Goserelin—Disturbance in sexual arousal—Topiramate—obesity	0.000408	0.000892	CcSEcCtD
Goserelin—Palpitations—Orlistat—obesity	0.000407	0.00089	CcSEcCtD
Goserelin—Angiopathy—Bupropion—obesity	0.000405	0.000886	CcSEcCtD
Goserelin—Migraine—Topiramate—obesity	0.000405	0.000885	CcSEcCtD
Goserelin—Affect lability—Topiramate—obesity	0.000405	0.000885	CcSEcCtD
Goserelin—Nausea—Cimetidine—obesity	0.000405	0.000884	CcSEcCtD
Goserelin—Immune system disorder—Bupropion—obesity	0.000404	0.000882	CcSEcCtD
Goserelin—Malaise—Sibutramine—obesity	0.000402	0.000879	CcSEcCtD
Goserelin—Cough—Orlistat—obesity	0.000402	0.000879	CcSEcCtD
Goserelin—Psychotic disorder—Topiramate—obesity	0.000402	0.000878	CcSEcCtD
Goserelin—Chills—Bupropion—obesity	0.000401	0.000876	CcSEcCtD
Goserelin—Convulsion—Orlistat—obesity	0.000399	0.000873	CcSEcCtD
Goserelin—Leukopenia—Sibutramine—obesity	0.000399	0.000873	CcSEcCtD
Goserelin—Arrhythmia—Bupropion—obesity	0.000399	0.000872	CcSEcCtD
Goserelin—Alopecia—Bupropion—obesity	0.000395	0.000863	CcSEcCtD
Goserelin—Palpitations—Sibutramine—obesity	0.000394	0.000861	CcSEcCtD
Goserelin—Myalgia—Orlistat—obesity	0.000393	0.000858	CcSEcCtD
Goserelin—Chest pain—Orlistat—obesity	0.000393	0.000858	CcSEcCtD
Goserelin—Mental disorder—Bupropion—obesity	0.000392	0.000855	CcSEcCtD
Goserelin—Urinary retention—Topiramate—obesity	0.000391	0.000855	CcSEcCtD
Goserelin—Anxiety—Orlistat—obesity	0.000391	0.000855	CcSEcCtD
Goserelin—Mood swings—Topiramate—obesity	0.00039	0.000852	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00039	0.000852	CcSEcCtD
Goserelin—Cough—Sibutramine—obesity	0.000389	0.000851	CcSEcCtD
Goserelin—Malnutrition—Bupropion—obesity	0.000389	0.00085	CcSEcCtD
Goserelin—Discomfort—Orlistat—obesity	0.000388	0.000847	CcSEcCtD
Goserelin—Convulsion—Sibutramine—obesity	0.000387	0.000845	CcSEcCtD
Goserelin—Hypertension—Sibutramine—obesity	0.000385	0.000842	CcSEcCtD
Goserelin—Dry mouth—Orlistat—obesity	0.000384	0.000839	CcSEcCtD
Goserelin—Flatulence—Bupropion—obesity	0.000383	0.000837	CcSEcCtD
Goserelin—Tension—Bupropion—obesity	0.000382	0.000834	CcSEcCtD
Goserelin—Arthralgia—Sibutramine—obesity	0.00038	0.00083	CcSEcCtD
Goserelin—Myalgia—Sibutramine—obesity	0.00038	0.00083	CcSEcCtD
Goserelin—Chest pain—Sibutramine—obesity	0.00038	0.00083	CcSEcCtD
Goserelin—Anxiety—Sibutramine—obesity	0.000379	0.000827	CcSEcCtD
Goserelin—Nervousness—Bupropion—obesity	0.000378	0.000825	CcSEcCtD
Goserelin—Anaphylactic shock—Orlistat—obesity	0.000376	0.000822	CcSEcCtD
Goserelin—Oedema—Orlistat—obesity	0.000376	0.000822	CcSEcCtD
Goserelin—Back pain—Bupropion—obesity	0.000376	0.000822	CcSEcCtD
Goserelin—Discomfort—Sibutramine—obesity	0.000375	0.00082	CcSEcCtD
Goserelin—Muscle spasms—Bupropion—obesity	0.000374	0.000817	CcSEcCtD
Goserelin—Infection—Orlistat—obesity	0.000374	0.000817	CcSEcCtD
Goserelin—Breast disorder—Topiramate—obesity	0.000372	0.000812	CcSEcCtD
Goserelin—Dry mouth—Sibutramine—obesity	0.000372	0.000812	CcSEcCtD
Goserelin—Nervous system disorder—Orlistat—obesity	0.000369	0.000806	CcSEcCtD
Goserelin—Confusional state—Sibutramine—obesity	0.000367	0.000802	CcSEcCtD
Goserelin—Vision blurred—Bupropion—obesity	0.000367	0.000801	CcSEcCtD
Goserelin—Skin disorder—Orlistat—obesity	0.000366	0.000799	CcSEcCtD
Goserelin—Oedema—Sibutramine—obesity	0.000364	0.000796	CcSEcCtD
Goserelin—Anaphylactic shock—Sibutramine—obesity	0.000364	0.000796	CcSEcCtD
Goserelin—Hyperhidrosis—Orlistat—obesity	0.000364	0.000795	CcSEcCtD
Goserelin—Infection—Sibutramine—obesity	0.000362	0.00079	CcSEcCtD
Goserelin—Ill-defined disorder—Bupropion—obesity	0.000361	0.000789	CcSEcCtD
Goserelin—Anaemia—Bupropion—obesity	0.00036	0.000785	CcSEcCtD
Goserelin—Shock—Sibutramine—obesity	0.000358	0.000783	CcSEcCtD
Goserelin—Thrombocytopenia—Sibutramine—obesity	0.000357	0.000779	CcSEcCtD
Goserelin—Tachycardia—Sibutramine—obesity	0.000355	0.000776	CcSEcCtD
Goserelin—Skin disorder—Sibutramine—obesity	0.000354	0.000773	CcSEcCtD
Goserelin—Hyperhidrosis—Sibutramine—obesity	0.000352	0.000769	CcSEcCtD
Goserelin—Malaise—Bupropion—obesity	0.000351	0.000766	CcSEcCtD
Goserelin—Leukopenia—Bupropion—obesity	0.000348	0.000761	CcSEcCtD
Goserelin—Anorexia—Sibutramine—obesity	0.000347	0.000758	CcSEcCtD
Goserelin—Angina pectoris—Topiramate—obesity	0.000346	0.000757	CcSEcCtD
Goserelin—Palpitations—Bupropion—obesity	0.000344	0.000751	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Orlistat—obesity	0.000343	0.000749	CcSEcCtD
Goserelin—Bronchitis—Topiramate—obesity	0.000342	0.000747	CcSEcCtD
Goserelin—Insomnia—Orlistat—obesity	0.00034	0.000744	CcSEcCtD
Goserelin—Hypotension—Sibutramine—obesity	0.00034	0.000743	CcSEcCtD
Goserelin—Cough—Bupropion—obesity	0.000339	0.000742	CcSEcCtD
Goserelin—Paraesthesia—Orlistat—obesity	0.000338	0.000738	CcSEcCtD
Goserelin—Convulsion—Bupropion—obesity	0.000337	0.000736	CcSEcCtD
Goserelin—Hypertension—Bupropion—obesity	0.000336	0.000734	CcSEcCtD
Goserelin—Dysuria—Topiramate—obesity	0.000333	0.000727	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Sibutramine—obesity	0.000332	0.000725	CcSEcCtD
Goserelin—Dyspepsia—Orlistat—obesity	0.000331	0.000724	CcSEcCtD
Goserelin—Chest pain—Bupropion—obesity	0.000331	0.000724	CcSEcCtD
Goserelin—Arthralgia—Bupropion—obesity	0.000331	0.000724	CcSEcCtD
Goserelin—Myalgia—Bupropion—obesity	0.000331	0.000724	CcSEcCtD
Goserelin—Upper respiratory tract infection—Topiramate—obesity	0.000331	0.000722	CcSEcCtD
Goserelin—Anxiety—Bupropion—obesity	0.00033	0.000721	CcSEcCtD
Goserelin—Insomnia—Sibutramine—obesity	0.000329	0.00072	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000329	0.000719	CcSEcCtD
Goserelin—Pollakiuria—Topiramate—obesity	0.000329	0.000718	CcSEcCtD
Goserelin—Erectile dysfunction—Topiramate—obesity	0.000328	0.000716	CcSEcCtD
Goserelin—Discomfort—Bupropion—obesity	0.000327	0.000715	CcSEcCtD
Goserelin—Decreased appetite—Orlistat—obesity	0.000327	0.000715	CcSEcCtD
Goserelin—Paraesthesia—Sibutramine—obesity	0.000327	0.000714	CcSEcCtD
Goserelin—Dyspnoea—Sibutramine—obesity	0.000325	0.000709	CcSEcCtD
Goserelin—Photosensitivity reaction—Topiramate—obesity	0.000325	0.000709	CcSEcCtD
Goserelin—Fatigue—Orlistat—obesity	0.000324	0.000709	CcSEcCtD
Goserelin—Dry mouth—Bupropion—obesity	0.000324	0.000708	CcSEcCtD
Goserelin—Somnolence—Sibutramine—obesity	0.000324	0.000707	CcSEcCtD
Goserelin—Weight increased—Topiramate—obesity	0.000324	0.000707	CcSEcCtD
Goserelin—Pain—Orlistat—obesity	0.000322	0.000703	CcSEcCtD
Goserelin—Hyperglycaemia—Topiramate—obesity	0.000321	0.000701	CcSEcCtD
Goserelin—Dyspepsia—Sibutramine—obesity	0.000321	0.0007	CcSEcCtD
Goserelin—Confusional state—Bupropion—obesity	0.00032	0.000699	CcSEcCtD
Goserelin—Pneumonia—Topiramate—obesity	0.000319	0.000697	CcSEcCtD
Goserelin—Anaphylactic shock—Bupropion—obesity	0.000317	0.000694	CcSEcCtD
Goserelin—Oedema—Bupropion—obesity	0.000317	0.000694	CcSEcCtD
Goserelin—Decreased appetite—Sibutramine—obesity	0.000317	0.000692	CcSEcCtD
Goserelin—Depression—Topiramate—obesity	0.000316	0.000691	CcSEcCtD
Goserelin—Infection—Bupropion—obesity	0.000315	0.000689	CcSEcCtD
Goserelin—Shock—Bupropion—obesity	0.000312	0.000682	CcSEcCtD
Goserelin—Renal failure—Topiramate—obesity	0.000312	0.000681	CcSEcCtD
Goserelin—Constipation—Sibutramine—obesity	0.000311	0.00068	CcSEcCtD
Goserelin—Pain—Sibutramine—obesity	0.000311	0.00068	CcSEcCtD
Goserelin—Nervous system disorder—Bupropion—obesity	0.000311	0.00068	CcSEcCtD
Goserelin—Thrombocytopenia—Bupropion—obesity	0.000311	0.000679	CcSEcCtD
Goserelin—Feeling abnormal—Orlistat—obesity	0.00031	0.000677	CcSEcCtD
Goserelin—Tachycardia—Bupropion—obesity	0.00031	0.000677	CcSEcCtD
Goserelin—Skin disorder—Bupropion—obesity	0.000308	0.000674	CcSEcCtD
Goserelin—Urinary tract infection—Topiramate—obesity	0.000308	0.000673	CcSEcCtD
Goserelin—Gastrointestinal pain—Orlistat—obesity	0.000308	0.000672	CcSEcCtD
Goserelin—Hyperhidrosis—Bupropion—obesity	0.000307	0.000671	CcSEcCtD
Goserelin—Anorexia—Bupropion—obesity	0.000303	0.000661	CcSEcCtD
Goserelin—Haematuria—Topiramate—obesity	0.000302	0.000661	CcSEcCtD
Goserelin—Feeling abnormal—Sibutramine—obesity	0.0003	0.000656	CcSEcCtD
Goserelin—Epistaxis—Topiramate—obesity	0.000299	0.000654	CcSEcCtD
Goserelin—Urticaria—Orlistat—obesity	0.000299	0.000653	CcSEcCtD
Goserelin—Gastrointestinal pain—Sibutramine—obesity	0.000298	0.000651	CcSEcCtD
Goserelin—Sinusitis—Topiramate—obesity	0.000298	0.00065	CcSEcCtD
Goserelin—Abdominal pain—Orlistat—obesity	0.000297	0.00065	CcSEcCtD
Goserelin—Body temperature increased—Orlistat—obesity	0.000297	0.00065	CcSEcCtD
Goserelin—Hypotension—Bupropion—obesity	0.000297	0.000648	CcSEcCtD
Goserelin—Urticaria—Sibutramine—obesity	0.000289	0.000632	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Bupropion—obesity	0.000289	0.000632	CcSEcCtD
Goserelin—Abdominal pain—Sibutramine—obesity	0.000288	0.000629	CcSEcCtD
Goserelin—Body temperature increased—Sibutramine—obesity	0.000288	0.000629	CcSEcCtD
Goserelin—Insomnia—Bupropion—obesity	0.000287	0.000627	CcSEcCtD
Goserelin—Haemoglobin—Topiramate—obesity	0.000286	0.000625	CcSEcCtD
Goserelin—Rhinitis—Topiramate—obesity	0.000285	0.000624	CcSEcCtD
Goserelin—Paraesthesia—Bupropion—obesity	0.000285	0.000623	CcSEcCtD
Goserelin—Haemorrhage—Topiramate—obesity	0.000285	0.000622	CcSEcCtD
Goserelin—Hepatitis—Topiramate—obesity	0.000285	0.000622	CcSEcCtD
Goserelin—Dyspnoea—Bupropion—obesity	0.000283	0.000618	CcSEcCtD
Goserelin—Pharyngitis—Topiramate—obesity	0.000283	0.000617	CcSEcCtD
Goserelin—Somnolence—Bupropion—obesity	0.000282	0.000617	CcSEcCtD
Goserelin—Urinary tract disorder—Topiramate—obesity	0.000281	0.000614	CcSEcCtD
Goserelin—Oedema peripheral—Topiramate—obesity	0.00028	0.000613	CcSEcCtD
Goserelin—Dyspepsia—Bupropion—obesity	0.000279	0.000611	CcSEcCtD
Goserelin—Urethral disorder—Topiramate—obesity	0.000279	0.00061	CcSEcCtD
Goserelin—Hypersensitivity—Orlistat—obesity	0.000277	0.000606	CcSEcCtD
Goserelin—Decreased appetite—Bupropion—obesity	0.000276	0.000603	CcSEcCtD
Goserelin—Fatigue—Bupropion—obesity	0.000274	0.000598	CcSEcCtD
Goserelin—Pain—Bupropion—obesity	0.000271	0.000593	CcSEcCtD
Goserelin—Constipation—Bupropion—obesity	0.000271	0.000593	CcSEcCtD
Goserelin—Asthenia—Orlistat—obesity	0.00027	0.00059	CcSEcCtD
Goserelin—Hypersensitivity—Sibutramine—obesity	0.000268	0.000586	CcSEcCtD
Goserelin—Pruritus—Orlistat—obesity	0.000266	0.000582	CcSEcCtD
Goserelin—Eye disorder—Topiramate—obesity	0.000266	0.000581	CcSEcCtD
Goserelin—Cardiac disorder—Topiramate—obesity	0.000264	0.000577	CcSEcCtD
Goserelin—Feeling abnormal—Bupropion—obesity	0.000262	0.000572	CcSEcCtD
Goserelin—Asthenia—Sibutramine—obesity	0.000261	0.000571	CcSEcCtD
Goserelin—Gastrointestinal pain—Bupropion—obesity	0.00026	0.000567	CcSEcCtD
Goserelin—Angiopathy—Topiramate—obesity	0.000258	0.000564	CcSEcCtD
Goserelin—Pruritus—Sibutramine—obesity	0.000258	0.000563	CcSEcCtD
Goserelin—Diarrhoea—Orlistat—obesity	0.000257	0.000562	CcSEcCtD
Goserelin—Immune system disorder—Topiramate—obesity	0.000257	0.000562	CcSEcCtD
Goserelin—Chills—Topiramate—obesity	0.000255	0.000558	CcSEcCtD
Goserelin—Urticaria—Bupropion—obesity	0.000252	0.000551	CcSEcCtD
Goserelin—Alopecia—Topiramate—obesity	0.000252	0.00055	CcSEcCtD
Goserelin—Abdominal pain—Bupropion—obesity	0.000251	0.000548	CcSEcCtD
Goserelin—Body temperature increased—Bupropion—obesity	0.000251	0.000548	CcSEcCtD
Goserelin—Mental disorder—Topiramate—obesity	0.000249	0.000545	CcSEcCtD
Goserelin—Diarrhoea—Sibutramine—obesity	0.000249	0.000544	CcSEcCtD
Goserelin—Dizziness—Orlistat—obesity	0.000249	0.000544	CcSEcCtD
Goserelin—Erythema—Topiramate—obesity	0.000248	0.000541	CcSEcCtD
Goserelin—Malnutrition—Topiramate—obesity	0.000248	0.000541	CcSEcCtD
Goserelin—Flatulence—Topiramate—obesity	0.000244	0.000534	CcSEcCtD
Goserelin—Tension—Topiramate—obesity	0.000243	0.000531	CcSEcCtD
Goserelin—Dizziness—Sibutramine—obesity	0.000241	0.000526	CcSEcCtD
Goserelin—Nervousness—Topiramate—obesity	0.000241	0.000526	CcSEcCtD
Goserelin—Back pain—Topiramate—obesity	0.00024	0.000524	CcSEcCtD
Goserelin—Vomiting—Orlistat—obesity	0.000239	0.000523	CcSEcCtD
Goserelin—Muscle spasms—Topiramate—obesity	0.000238	0.000521	CcSEcCtD
Goserelin—Rash—Orlistat—obesity	0.000237	0.000518	CcSEcCtD
Goserelin—Dermatitis—Orlistat—obesity	0.000237	0.000518	CcSEcCtD
Goserelin—Headache—Orlistat—obesity	0.000236	0.000515	CcSEcCtD
Goserelin—Hypersensitivity—Bupropion—obesity	0.000234	0.000511	CcSEcCtD
Goserelin—Vision blurred—Topiramate—obesity	0.000234	0.00051	CcSEcCtD
Goserelin—Vomiting—Sibutramine—obesity	0.000232	0.000506	CcSEcCtD
Goserelin—Ill-defined disorder—Topiramate—obesity	0.00023	0.000502	CcSEcCtD
Goserelin—Rash—Sibutramine—obesity	0.00023	0.000502	CcSEcCtD
Goserelin—Dermatitis—Sibutramine—obesity	0.000229	0.000501	CcSEcCtD
Goserelin—Anaemia—Topiramate—obesity	0.000229	0.0005	CcSEcCtD
Goserelin—Headache—Sibutramine—obesity	0.000228	0.000498	CcSEcCtD
Goserelin—Asthenia—Bupropion—obesity	0.000228	0.000498	CcSEcCtD
Goserelin—Pruritus—Bupropion—obesity	0.000225	0.000491	CcSEcCtD
Goserelin—Nausea—Orlistat—obesity	0.000224	0.000488	CcSEcCtD
Goserelin—Malaise—Topiramate—obesity	0.000224	0.000488	CcSEcCtD
Goserelin—Leukopenia—Topiramate—obesity	0.000222	0.000485	CcSEcCtD
Goserelin—Palpitations—Topiramate—obesity	0.000219	0.000478	CcSEcCtD
Goserelin—Diarrhoea—Bupropion—obesity	0.000217	0.000475	CcSEcCtD
Goserelin—Nausea—Sibutramine—obesity	0.000216	0.000473	CcSEcCtD
Goserelin—Cough—Topiramate—obesity	0.000216	0.000472	CcSEcCtD
Goserelin—Convulsion—Topiramate—obesity	0.000215	0.000469	CcSEcCtD
Goserelin—Hypertension—Topiramate—obesity	0.000214	0.000467	CcSEcCtD
Goserelin—Myalgia—Topiramate—obesity	0.000211	0.000461	CcSEcCtD
Goserelin—Chest pain—Topiramate—obesity	0.000211	0.000461	CcSEcCtD
Goserelin—Arthralgia—Topiramate—obesity	0.000211	0.000461	CcSEcCtD
Goserelin—Anxiety—Topiramate—obesity	0.00021	0.000459	CcSEcCtD
Goserelin—Dizziness—Bupropion—obesity	0.00021	0.000459	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00021	0.000458	CcSEcCtD
Goserelin—Discomfort—Topiramate—obesity	0.000208	0.000455	CcSEcCtD
Goserelin—Dry mouth—Topiramate—obesity	0.000206	0.000451	CcSEcCtD
Goserelin—Confusional state—Topiramate—obesity	0.000204	0.000446	CcSEcCtD
Goserelin—Oedema—Topiramate—obesity	0.000202	0.000442	CcSEcCtD
Goserelin—Vomiting—Bupropion—obesity	0.000202	0.000441	CcSEcCtD
Goserelin—Infection—Topiramate—obesity	0.000201	0.000439	CcSEcCtD
Goserelin—Rash—Bupropion—obesity	0.0002	0.000437	CcSEcCtD
Goserelin—Dermatitis—Bupropion—obesity	0.0002	0.000437	CcSEcCtD
Goserelin—Shock—Topiramate—obesity	0.000199	0.000435	CcSEcCtD
Goserelin—Headache—Bupropion—obesity	0.000199	0.000435	CcSEcCtD
Goserelin—Nervous system disorder—Topiramate—obesity	0.000198	0.000433	CcSEcCtD
Goserelin—Thrombocytopenia—Topiramate—obesity	0.000198	0.000433	CcSEcCtD
Goserelin—Tachycardia—Topiramate—obesity	0.000197	0.000431	CcSEcCtD
Goserelin—Skin disorder—Topiramate—obesity	0.000196	0.000429	CcSEcCtD
Goserelin—Hyperhidrosis—Topiramate—obesity	0.000196	0.000427	CcSEcCtD
Goserelin—Anorexia—Topiramate—obesity	0.000193	0.000421	CcSEcCtD
Goserelin—Hypotension—Topiramate—obesity	0.000189	0.000413	CcSEcCtD
Goserelin—Nausea—Bupropion—obesity	0.000189	0.000412	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Topiramate—obesity	0.000184	0.000403	CcSEcCtD
Goserelin—Insomnia—Topiramate—obesity	0.000183	0.0004	CcSEcCtD
Goserelin—Paraesthesia—Topiramate—obesity	0.000182	0.000397	CcSEcCtD
Goserelin—Dyspnoea—Topiramate—obesity	0.00018	0.000394	CcSEcCtD
Goserelin—Somnolence—Topiramate—obesity	0.00018	0.000393	CcSEcCtD
Goserelin—Dyspepsia—Topiramate—obesity	0.000178	0.000389	CcSEcCtD
Goserelin—Decreased appetite—Topiramate—obesity	0.000176	0.000384	CcSEcCtD
Goserelin—Fatigue—Topiramate—obesity	0.000174	0.000381	CcSEcCtD
Goserelin—Constipation—Topiramate—obesity	0.000173	0.000378	CcSEcCtD
Goserelin—Pain—Topiramate—obesity	0.000173	0.000378	CcSEcCtD
Goserelin—Feeling abnormal—Topiramate—obesity	0.000167	0.000364	CcSEcCtD
Goserelin—Gastrointestinal pain—Topiramate—obesity	0.000165	0.000361	CcSEcCtD
Goserelin—Urticaria—Topiramate—obesity	0.000161	0.000351	CcSEcCtD
Goserelin—Abdominal pain—Topiramate—obesity	0.00016	0.000349	CcSEcCtD
Goserelin—Body temperature increased—Topiramate—obesity	0.00016	0.000349	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—PRKCD—obesity	0.000158	0.000459	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PPY—obesity	0.000157	0.000458	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NPS—obesity	0.000156	0.000454	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCH—obesity	0.000155	0.000449	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NCF2—obesity	0.000155	0.000449	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC8—obesity	0.000155	0.000449	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GIP—obesity	0.000155	0.000449	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—HTR2A—obesity	0.000154	0.000449	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—C3—obesity	0.000154	0.000448	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—DRD1—obesity	0.000153	0.000445	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR2C—obesity	0.000153	0.000445	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR1—obesity	0.000151	0.00044	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NPY—obesity	0.000151	0.000438	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IAPP—obesity	0.00015	0.000435	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOC3—obesity	0.00015	0.000435	CbGpPWpGaD
Goserelin—Hypersensitivity—Topiramate—obesity	0.000149	0.000326	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRB1—obesity	0.000148	0.000431	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—DRD2—obesity	0.000148	0.000429	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEPR—obesity	0.000147	0.000427	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AGT—obesity	0.000147	0.000426	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GCG—obesity	0.000146	0.000425	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—POMC—obesity	0.000146	0.000425	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HTR1B—obesity	0.000145	0.000422	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CRH—obesity	0.000145	0.000422	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GHRL—obesity	0.000145	0.000422	CbGpPWpGaD
Goserelin—Asthenia—Topiramate—obesity	0.000145	0.000317	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—DRD4—obesity	0.000144	0.000418	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SDC1—obesity	0.000144	0.000418	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PRKCD—obesity	0.000143	0.000417	CbGpPWpGaD
Goserelin—Pruritus—Topiramate—obesity	0.000143	0.000313	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CCL2—obesity	0.000143	0.000416	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—PIK3CA—obesity	0.000142	0.000413	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKR1C3—obesity	0.000141	0.000411	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HTR2A—obesity	0.00014	0.000408	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—C3—obesity	0.00014	0.000407	CbGpPWpGaD
Goserelin—Diarrhoea—Topiramate—obesity	0.000138	0.000302	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NPS—obesity	0.000138	0.0004	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR1—obesity	0.000137	0.000399	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—F2—obesity	0.000135	0.000394	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PRKCB—obesity	0.000135	0.000394	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HTR2C—obesity	0.000135	0.000393	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DRD1—obesity	0.000135	0.000393	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—DRD2—obesity	0.000134	0.00039	CbGpPWpGaD
Goserelin—Dizziness—Topiramate—obesity	0.000134	0.000292	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AGT—obesity	0.000133	0.000387	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GCG—obesity	0.000133	0.000386	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRB2—obesity	0.000132	0.000384	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTRK2—obesity	0.000131	0.000382	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB3—obesity	0.000131	0.000382	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRB1—obesity	0.000131	0.00038	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CG—obesity	0.00013	0.000377	CbGpPWpGaD
Goserelin—Vomiting—Topiramate—obesity	0.000129	0.000281	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GAL—obesity	0.000128	0.000373	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GHRL—obesity	0.000128	0.000372	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PARP1—obesity	0.000128	0.000372	CbGpPWpGaD
Goserelin—Rash—Topiramate—obesity	0.000128	0.000279	CcSEcCtD
Goserelin—Dermatitis—Topiramate—obesity	0.000127	0.000278	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	0.000127	0.00037	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DRD4—obesity	0.000127	0.000369	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—C5AR1—obesity	0.000127	0.000369	CbGpPWpGaD
Goserelin—Headache—Topiramate—obesity	0.000127	0.000277	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—GNB3—obesity	0.000126	0.000366	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—POMC—obesity	0.000123	0.000359	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PRKCB—obesity	0.000123	0.000357	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—F2—obesity	0.000123	0.000357	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GNAS—obesity	0.000123	0.000356	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR1—obesity	0.000121	0.000352	CbGpPWpGaD
Goserelin—Nausea—Topiramate—obesity	0.00012	0.000262	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRB2—obesity	0.00012	0.000349	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TCF7L2—obesity	0.000119	0.000346	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT2—obesity	0.000119	0.000345	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DRD2—obesity	0.000118	0.000344	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CG—obesity	0.000118	0.000342	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—obesity	0.000117	0.000341	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTPN1—obesity	0.000117	0.00034	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GCG—obesity	0.000117	0.00034	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKG1—obesity	0.000116	0.000337	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCK—obesity	0.000116	0.000337	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNB3—obesity	0.000114	0.000332	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CD—obesity	0.000114	0.000331	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RBP4—obesity	0.000113	0.000329	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLP1R—obesity	0.000113	0.000329	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	0.000113	0.000327	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—POMC—obesity	0.000112	0.000326	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRL—obesity	0.000112	0.000325	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNAS—obesity	0.000111	0.000324	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRH3—obesity	0.000111	0.000323	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCKAR—obesity	0.000111	0.000323	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STK11—obesity	0.00011	0.00032	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL2—obesity	0.00011	0.000319	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLG—obesity	0.000109	0.000316	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RHOA—obesity	0.000109	0.000316	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT2—obesity	0.000108	0.000313	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3R1—obesity	0.000108	0.000313	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKAR2B—obesity	0.000107	0.000311	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL5—obesity	0.000107	0.00031	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FOXO3—obesity	0.000106	0.000309	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRB2—obesity	0.000106	0.000308	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCD—obesity	0.000106	0.000307	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOCS1—obesity	0.000104	0.000303	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CD—obesity	0.000103	0.000301	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCF2—obesity	0.000103	0.000301	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR2A—obesity	0.000103	0.000301	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—C3—obesity	0.000103	0.0003	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOCS3—obesity	0.000103	0.0003	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNB3—obesity	0.000101	0.000293	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPY—obesity	0.000101	0.000293	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IAPP—obesity	0.0001	0.000291	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOC3—obesity	0.0001	0.000291	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—TYK2—obesity	9.96e-05	0.000289	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CB—obesity	9.93e-05	0.000289	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF2—obesity	9.92e-05	0.000288	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RHOA—obesity	9.87e-05	0.000287	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNAS—obesity	9.83e-05	0.000286	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGT—obesity	9.81e-05	0.000285	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3R1—obesity	9.77e-05	0.000284	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR1B—obesity	9.73e-05	0.000283	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CRH—obesity	9.73e-05	0.000283	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOB—obesity	9.63e-05	0.00028	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SDC1—obesity	9.62e-05	0.00028	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCD—obesity	9.6e-05	0.000279	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKR1C3—obesity	9.46e-05	0.000275	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL5—obesity	9.4e-05	0.000273	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR2A—obesity	9.39e-05	0.000273	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—C3—obesity	9.38e-05	0.000273	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPS—obesity	9.22e-05	0.000268	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LPL—obesity	9.19e-05	0.000267	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FOXO1—obesity	9.13e-05	0.000265	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RPS6KB1—obesity	9.11e-05	0.000265	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2—obesity	9.07e-05	0.000263	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCB—obesity	9.07e-05	0.000263	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2C—obesity	9.04e-05	0.000263	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DRD1—obesity	9.04e-05	0.000263	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CB—obesity	9.02e-05	0.000262	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGT—obesity	8.91e-05	0.000259	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NTRK2—obesity	8.8e-05	0.000256	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB1—obesity	8.76e-05	0.000255	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CG—obesity	8.68e-05	0.000252	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PARP1—obesity	8.57e-05	0.000249	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GHRL—obesity	8.57e-05	0.000249	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DRD4—obesity	8.5e-05	0.000247	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCD—obesity	8.47e-05	0.000246	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HTR2A—obesity	8.29e-05	0.000241	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—C3—obesity	8.28e-05	0.00024	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—POMC—obesity	8.26e-05	0.00024	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCB—obesity	8.23e-05	0.000239	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2—obesity	8.23e-05	0.000239	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CNR1—obesity	8.12e-05	0.000236	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TCF7L2—obesity	7.98e-05	0.000232	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT2—obesity	7.94e-05	0.000231	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DRD2—obesity	7.92e-05	0.00023	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CG—obesity	7.88e-05	0.000229	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS2—obesity	7.87e-05	0.000229	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGT—obesity	7.86e-05	0.000228	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTPN1—obesity	7.84e-05	0.000228	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GCG—obesity	7.84e-05	0.000228	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LEP—obesity	7.71e-05	0.000224	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOE—obesity	7.71e-05	0.000224	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CAV1—obesity	7.63e-05	0.000222	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CD—obesity	7.63e-05	0.000222	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOA1—obesity	7.62e-05	0.000221	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—POMC—obesity	7.5e-05	0.000218	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRL—obesity	7.48e-05	0.000217	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STK11—obesity	7.37e-05	0.000214	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ESR1—obesity	7.36e-05	0.000214	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—obesity	7.34e-05	0.000213	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLG—obesity	7.29e-05	0.000212	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—RHOA—obesity	7.28e-05	0.000211	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCB—obesity	7.27e-05	0.000211	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2—obesity	7.27e-05	0.000211	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT2—obesity	7.21e-05	0.000209	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3R1—obesity	7.2e-05	0.000209	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BAD—obesity	7.18e-05	0.000209	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FOXO3—obesity	7.12e-05	0.000207	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB2—obesity	7.1e-05	0.000206	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS1—obesity	6.99e-05	0.000203	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CG—obesity	6.95e-05	0.000202	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CD—obesity	6.93e-05	0.000201	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS3—obesity	6.9e-05	0.000201	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS1—obesity	6.87e-05	0.0002	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNB3—obesity	6.76e-05	0.000196	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—TYK2—obesity	6.66e-05	0.000194	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CB—obesity	6.65e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF2—obesity	6.64e-05	0.000193	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—POMC—obesity	6.62e-05	0.000192	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RHOA—obesity	6.61e-05	0.000192	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INS—obesity	6.58e-05	0.000191	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNAS—obesity	6.58e-05	0.000191	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3R1—obesity	6.54e-05	0.00019	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—obesity	6.48e-05	0.000188	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOB—obesity	6.44e-05	0.000187	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—obesity	6.37e-05	0.000185	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT2—obesity	6.36e-05	0.000185	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL5—obesity	6.29e-05	0.000183	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LPL—obesity	6.15e-05	0.000179	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CD—obesity	6.11e-05	0.000178	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FOXO1—obesity	6.11e-05	0.000178	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RPS6KB1—obesity	6.1e-05	0.000177	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—obesity	6.05e-05	0.000176	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—obesity	6.05e-05	0.000176	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CB—obesity	6.04e-05	0.000175	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TYK2—obesity	5.88e-05	0.000171	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RHOA—obesity	5.83e-05	0.000169	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3R1—obesity	5.77e-05	0.000168	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—obesity	5.77e-05	0.000168	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCD—obesity	5.67e-05	0.000165	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2A—obesity	5.55e-05	0.000161	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—C3—obesity	5.54e-05	0.000161	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—obesity	5.5e-05	0.00016	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTOR—obesity	5.33e-05	0.000155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CB—obesity	5.33e-05	0.000155	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS2—obesity	5.27e-05	0.000153	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—obesity	5.26e-05	0.000153	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—obesity	5.16e-05	0.00015	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—obesity	5.16e-05	0.00015	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CAV1—obesity	5.11e-05	0.000148	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—obesity	5.1e-05	0.000148	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—obesity	4.95e-05	0.000144	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ESR1—obesity	4.92e-05	0.000143	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—obesity	4.87e-05	0.000141	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2—obesity	4.86e-05	0.000141	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCB—obesity	4.86e-05	0.000141	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BAD—obesity	4.81e-05	0.00014	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CG—obesity	4.66e-05	0.000135	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—obesity	4.63e-05	0.000135	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS1—obesity	4.6e-05	0.000134	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK8—obesity	4.5e-05	0.000131	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—obesity	4.49e-05	0.000131	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—obesity	4.43e-05	0.000129	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INS—obesity	4.41e-05	0.000128	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—obesity	4.34e-05	0.000126	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—obesity	4.26e-05	0.000124	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT2—obesity	4.26e-05	0.000124	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—obesity	4.12e-05	0.00012	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CD—obesity	4.09e-05	0.000119	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—obesity	4.05e-05	0.000118	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—obesity	4.05e-05	0.000118	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TYK2—obesity	3.94e-05	0.000114	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RHOA—obesity	3.9e-05	0.000113	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3R1—obesity	3.86e-05	0.000112	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—obesity	3.86e-05	0.000112	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—obesity	3.83e-05	0.000111	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—obesity	3.82e-05	0.000111	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—obesity	3.68e-05	0.000107	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CB—obesity	3.57e-05	0.000104	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTOR—obesity	3.57e-05	0.000104	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—obesity	3.31e-05	9.62e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—obesity	3.26e-05	9.47e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—obesity	3.25e-05	9.44e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—obesity	3.1e-05	9.01e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK8—obesity	3.02e-05	8.76e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—obesity	3.01e-05	8.74e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—obesity	2.88e-05	8.36e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—obesity	2.76e-05	8.01e-05	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—obesity	2.65e-05	7.71e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—obesity	2.56e-05	7.44e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—obesity	2.56e-05	7.42e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—obesity	2.17e-05	6.32e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—obesity	1.93e-05	5.59e-05	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—obesity	1.78e-05	5.16e-05	CbGpPWpGaD
